O'Day R - Search Results

1

Oral Sirolimus for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome.

Kalantary A, Halbert A, Franchina M, Heath Jeffery RC, O'Day R, Chen FK. Kalantary A, et al. Among authors: o day r. JAMA Ophthalmol. 2024 Apr 18. doi: 10.1001/jamaophthalmol.2024.0854. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 38635233

2

Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma.

Flanagan JPM, Fog LS, Astrahan MA, Talbot LJ, McKay D, Phillips C, McKenzie JD, O'Day R. Flanagan JPM, et al. Among authors: o day r. Can J Ophthalmol. 2024 Apr 4:S0008-4182(24)00074-7. doi: 10.1016/j.jcjo.2024.03.007. Online ahead of print. Can J Ophthalmol. 2024. PMID: 38582499 Free article.

3

Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.

Flanagan JPM, Udovenya WHF, Astrahan MA, McKay D, Phillips C, McKenzie JD, O'Day R, Fog LS. Flanagan JPM, et al. Among authors: o day r. J Contemp Brachytherapy. 2023 Dec;15(6):442-447. doi: 10.5114/jcb.2023.133614. Epub 2023 Dec 9. J Contemp Brachytherapy. 2023. PMID: 38230400 Free PMC article.

4

Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma.

Hiong A, O'Day R, Fog LS, McKay D, McKenzie J, Ameratunga M, Joshua AM, Shackleton M. Hiong A, et al. Among authors: o day r. Ophthalmol Retina. 2024 Apr;8(4):325-330. doi: 10.1016/j.oret.2023.10.009. Epub 2023 Oct 17. Ophthalmol Retina. 2024. PMID: 37852320

5

Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma.

International Vitreoretinal B-Cell Lymphoma Registry Investigator Group. International Vitreoretinal B-Cell Lymphoma Registry Investigator Group. Ophthalmol Retina. 2024 Jan;8(1):72-80. doi: 10.1016/j.oret.2023.08.012. Epub 2023 Aug 28. Ophthalmol Retina. 2024. PMID: 37648063 Free article.

6

De novo choroidal osteoma after laser photocoagulation of a peripapillary choroidal neovascular membrane.

Salehi O, Harper CA, Guymer R, O'Day R. Salehi O, et al. Among authors: o day r. Oman J Ophthalmol. 2023 Feb 21;16(1):151-153. doi: 10.4103/ojo.ojo_83_22. eCollection 2023 Jan-Apr. Oman J Ophthalmol. 2023. PMID: 37007225 Free PMC article.

7

Trans-scleral uveal melanoma biopsy: can it be safely and accurately incorporated into a medium volume ocular oncology service?

O'Day RF, McKelvie P, Cherepanoff S, McKay D. O'Day RF, et al. Int Ophthalmol. 2023 Jul;43(7):2139-2141. doi: 10.1007/s10792-023-02647-9. Epub 2023 Mar 2. Int Ophthalmol. 2023. PMID: 36864122 No abstract available.

8

Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision.

Fionda B, Pagliara MM, Chyrek AJ, Guix B, O'Day RFJ, Fog LS, Martínez-Monge R, Tagliaferri L. Fionda B, et al. Among authors: o day rfj. Clin Oncol (R Coll Radiol). 2023 Aug;35(8):e445-e452. doi: 10.1016/j.clon.2023.01.021. Epub 2023 Feb 6. Clin Oncol (R Coll Radiol). 2023. PMID: 36792447

9

Case Series: Presumed Choroidal Melanoma Diagnosis Expedited by Documented Growth on Serial Optical Coherence Tomography.

O'Day RFJ, McKay D, McKenzie JD, van Wijngaarden P. O'Day RFJ, et al. Optom Vis Sci. 2022 Sep 1;99(9):725-729. doi: 10.1097/OPX.0000000000001915. Epub 2022 Jun 9. Optom Vis Sci. 2022. PMID: 35678637

10

Tetrasomy of chromosomes 3 and 8 in a young male with choroidal melanoma.

O'Day R, Grantham M, Thaung C, Szlosarek P, Sagoo MS. O'Day R, et al. Melanoma Res. 2022 Apr 1;32(2):132-133. doi: 10.1097/CMR.0000000000000802. Melanoma Res. 2022. PMID: 35254338 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page